Alginor is a marine biotech company focused on developing a biorefinery. The company is advancing the next step of its biorefinery expansion and has raised capital to fund that work. Borregaard has participated in the funding and pre-committed its share. Committed investments from Borregaard into Alginor will total approximately NOK 408 million after the transaction. Alginor plans a repair offering directed towards existing and potential new shareholders. A subsequent offering will be made towards Borregaard to ensure it retains a 35% fully diluted ownership stake.

Total raised

$38M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2024